Literature DB >> 21836515

The long-term liver graft and protocol biopsy: do we want to look? What will we find?

Udeme D Ekong1.   

Abstract

PURPOSE OF REVIEW: Histological abnormalities are commonly present in late posttransplant biopsies. Many of these changes are seen in recipients who are clinically well with good graft function. This review includes discussion of a small number of studies published within the past 18 months and details future directions in this area of research. RECENT
FINDINGS: An analysis of protocol liver biopsies in adult liver allograft recipients revealed normal or near normal histology in less than one third of recipients. Idiopathic chronic hepatitis (not related to disease recurrence) was present in 33%. Interpreted in light of the calculated creatinine clearance, the histological findings led to a documented change in immunosuppression in 32% of the recipients studied. Another study that assessed the natural history of graft fibrosis after pediatric liver transplantation revealed that fibrosis was strongly related to transplant-related factors, and that by 10 years following liver transplantation, the severity had progressed in 25% of the studied recipients.
SUMMARY: Current studies suggest protocol liver biopsies may provide important histological information about graft function that is not available from standard liver tests and may allow modification of immunosuppression to ensure long-term side-effects of drug therapy are minimized while graft function is maintained.

Entities:  

Mesh:

Year:  2011        PMID: 21836515     DOI: 10.1097/MOT.0b013e32834a8caf

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  7 in total

1.  Tailored long-term immunosuppressive regimen for adult liver transplant recipients with hepatocellular carcinoma.

Authors:  Sung-Hwa Kang; Shin Hwang; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Ki-Hun Kim; Chul-Soo Ahn; Deok-Bog Moon; Gil-Chun Park; Bo-Hyun Jung; Young-In Yoon; Sung-Gyu Lee
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2014-05-31

2.  Hepatic steatosis after pediatric liver transplant.

Authors:  Emily R Perito; Tabitha Vase; Rageshree Ramachandran; Andrew Phelps; Kuang-Yu Jen; Robert H Lustig; Vickie A Feldstein; Philip Rosenthal
Journal:  Liver Transpl       Date:  2017-07       Impact factor: 5.799

Review 3.  Progress in abdominal organ transplantation.

Authors:  Maciej Kosieradzki; Wojciech Lisik; Wojciech Rowiński; Piotr Małkowski
Journal:  Med Sci Monit       Date:  2011-12

4.  Clinical Value of Surveillance Biopsies in Pediatric Liver Transplantation.

Authors:  Brittany Rocque; Aaron Zaldana; Carly Weaver; Julia Huang; Arianna Barbetta; Victoria Shakhin; Cameron Goldbeck; George Yanni; Shannon Zielsdorf; Yong Kwon; Kambiz Etesami; Yuri Genyk; Shengmei Zhou; Rohit Kohli; Juliet Emamaullee
Journal:  Liver Transpl       Date:  2022-01-20       Impact factor: 6.112

5.  A cross-sectional analysis of long-term immunosuppressive regimens after liver transplantation at Asan Medical Center: Increased preference for mycophenolate mofetil.

Authors:  Shin Hwang; Chul-Soo Ahn; Ki-Hun Kim; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Gil-Chun Park; Sung-Gyu Lee
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2018-02-26

6.  Value of posttransplant protocol biopsies in 2 biliary autoimmune liver diseases: A step toward personalized immunosuppressive treatment.

Authors:  Marko Vannas; Johanna Arola; Arno Nordin; Helena Isoniemi
Journal:  Medicine (Baltimore)       Date:  2022-01-14       Impact factor: 1.817

7.  Histopathological causes of late liver allograft dysfunction: analysis at a single institution.

Authors:  Eun Shin; Ji Hoon Kim; Eunsil Yu
Journal:  Korean J Pathol       Date:  2013-02-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.